Imperial College London


Faculty of MedicineDepartment of Metabolism, Digestion and Reproduction

Wynn Chair in Human Metabolism (Clinical)



+44 (0)20 7594 1796nick.oliver




7S7aCommonwealth BuildingHammersmith Campus





Nick is the Wynn professor of human metabolism and is a consultant in diabetes and endocrinology at Imperial College Healthcare NHS Trust. His clinical and academic interest is how technologies can be developed and applied to meet the challenges of living with type 1 diabetes.



Godsland I, Johnston DG, Alberti KGMM, et al., 2024, The importance of intravenous glucose tolerance test glucose stimulus for the evaluation of insulin secretion, Scientific Reports, ISSN:2045-2322

Preechasuk L, Oliver N, Avari P, et al., 2024, Switching from Intermittently Scanned Continuous Glucose Monitoring to Real Time Continuous Glucose Monitoring with a predictive urgent low soon alert reduces exposure to hypoglycaemia., Diabetes Technol Ther

Jendle J, Adolfsson P, Choudhary P, et al., 2024, A narrative commentary about interoperability in medical devices and data used in diabetes therapy from an academic EU/UK/US perspective., Diabetologia, Vol:67, Pages:236-245

Rilstone S, Oliver N, Godsland I, et al., 2024, A Randomized Controlled Trial Assessing the Impact of Continuous Glucose Monitoring with a Predictive Hypoglycemia Alert Function on Hypoglycemia in Physical Activity for People with Type 1 Diabetes (PACE)., Diabetes Technol Ther, Vol:26, Pages:95-102

Oliver N, 2024, Baby steps., Diabet Med, Vol:41

More Publications